By Bob Kronemyer
Originally posted on Pain Medicine News
U.S. veterans with moderate to high rheumatoid arthritis (RA) activity achieved significant clinical improvement after a major therapeutic change (MTC), according to a study in Arthritis Research and Therapy (2020;22[1]:253).
The researchers defined MTC as initiating or restarting a disease-modifying antirheumatic drug (DMARD) or prednisone, a DMARD or a prednisone dose increase of at least 25%, or two or more intra-articular corticosteroid